Search results

Page results

• Steroid treatment for inflammation caused by immunotherapy

  This information is for patients receiving steroids for immunotherapy toxicity.

• Using data in research

  How UCLH uses clinical data in research.

• Oxbryta (Voxelotor) withdrawal from the UK market in the treatment of Sickle Cell Disorder in people aged 12 years and older

  Pfizer Limited, in agreement with the Medicines Healthcare products Regulatory Agency (MHRA), has withdrawn the product, while a review of the benefits and risks is carried out.

• Cancer immunotherapy treatment

  This page is for patients receiving steroids for immunotherapy toxicity.

• Treating acute lymphoblastic leukaemia (ALL)

  Your treatment for acute lymphoblastic leukaemia (ALL) will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.

• Study reveals limitations of drug proposed for lung cancer treatment

  Researchers at UCLH and UCL have completed the first and only randomised trial to explore a new approach to treating aggressive lung cancer.

• What is acute lymphoblastic leukaemia (ALL)

  Acute lymphoblastic leukaemia (ALL) is a form of cancer that affects the cells in the bone marrow, the soft material inside your bones.

• National Hospital for Neurology and Neurosurgery at Cleveland Street

  The National Hospital for Neurosurgery at Cleveland Street opened its doors to patients on 4 April 2016. This brand new centre was developed to provide a new home for our Pain Management Centre, a nationally recognized centre of excellence for people with longstanding pain. Set over two floors the centre has group rooms and consulting clinic rooms as well as procedure rooms.Some multiple sclerosis clinics and outpatient appointments for the National Prion Clinic are also held at the centre.

• Treating acute myeloid leukaemia (AML)

  Your acute myeloid leukaemia (AML) treatment will be delivered within a number of comprehensive specialised services led by medical and nursing cancer care experts.

• National Hospital for Neurology and Neurosurgery

  The National Hospital for Neurology and Neurosurgery (NHNN), Queen Square, is the UK's largest dedicated neurological and neurosurgical hospital. It provides comprehensive services for the diagnosis, treatment and care of all conditions that affect the brain, spinal cord, peripheral nervous system and muscles. Services include specialist neurosurgery, a brain tumour unit, the Hyper-acute Stroke Unit (HASU), an acute brain injury unit, the National Prion Clinic, a pioneering neuro-rehabilitation unit, the UK's first interventional MRI scanner, the largest specialised neurosurgical ITU and the only neuromedical ITU in the country. Together with its neighbour, the UCL Queen Square Institute of Neurology, it is a major international centre for research and training.